Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20160503001Completed
Open-label, single-arm trial of lipoxin A4, sponsored by Thammasat University. Primary endpoints: Anti-inflammatory effect of lipoxin A4, Superoxide anion generation in neutrophils and 2 more. Started Jul 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20160503001.